Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 195
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
Over 55
Other
GMALL02
NCT00198978
2.
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL01
NCT00198991
3.
Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL03
NCT00199004
4.
Trial for the Treatment of Newly Diagnosed Mature B-Cell Acute Lymphoblastic Leukemia (B-ALL), Burkitt's Non-Hodgkin's Lymphoma (NHL) and Other High-Grade Lymphoma in Adults
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
Over 15
Other
GMALL05
NCT00199082
5.
An Expanded Access Program For Lenalidomide Plus Dexamethasone In Previously Treated Subjects With Multiple Myeloma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
18 and over
Pharmaceutical / Industry
CC-5013-MM-016
NCT00179647
6.
Oral Neurokinin-1 Antagonist, Aprepitant, in Combination With Ondansetron and Dexamethasone in Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Supportive care
Active
18 and over
Other
hsc 031192
ind 70268, NCT00285272
7.
Study Treatment to Low Risk ALL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 and under
Other
LAL-BR/2001
NCT00526175
8.
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
65 and under
Other
LAL-Ph-2000
NCT00526305
9.
Study Treatment for Children High Risk Acute Lymphoblastic Leukemia
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
16 and under
Other
LAL-AR-N-2005
NCT00526409
10.
German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase IV
Treatment
Active
15 to 65
Other
GMALL04
NCT00199017
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute